Phosphatidylcholine (PC) decreases the nuclear c-Fos and c-Jun protein levels under lipopolysaccharide (LPS) stimulation in MG6 cells. by Sachiko Mizuno (21799645)

Genistein decreases mouse liver lnfection by <i>P. berghei</i> ANKA sporozoites. by Margarida Cunha-Rodrigues (65513)

Losartan decreases vessel size but not effect microvessel density or pericyte recruitment in Pan02 tumors grown in <i>SPARC−/−</i> animals. by Shanna A. Arnold (183991)

Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF- by Wencheng Jin (13136262)

VANGL2 recruits NLRP3 to OPTN for selective autophagic degradation. by Huaji Jiang (16907514)

Gal-3 is upregulated in hypoxia in NG97ht cells. by Rafael Yamashita Ikemori (698128)

OPG147 has no effect on TBK1 or IRF3-mediated ISRE activation and HT-DNA-induced signaling. by Xue-Mei Yi (18851202)

mPEG PV1-Fab’ dampens IFN-γ production by CD4⁺ T lymphocytes. by Pedro Henrique Papotto (791904)

Measurements of body mass index (BMI) and adipose deposits. by Jessica C. M. Hui (20370522)

DKT promoted the repair of the mucosal barrier and nutrient absorption functions. by Peilin Li (586356)

NR4A1 plays a role in RCC proliferation. by Erik Hedrick (748501)

“…(D) Cells were transfected with NBRE₃-luc and 40 ng FLAG-NR4A1, treated with DMSO, DIM-C-pPhOH (20 μM) and DIM-C-pPhCO₂Me (15 μM), and luciferase activity was determined as described [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0128308#pone.0128308.ref017" target="_blank">17</a>]. …”

GRP-R mAb-1 inhibitory roles on neuroblastoma cell <i>in vitro</i>. by Jingbo Qiao (382330)

Antepartum fibrinogen concentration as a predictor of bleeding complications by Laura E. Dodge (7875416)

Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model by Genmin Lu (5029949)

“…In edoxaban-anticoagulated rabbits, andexanet reduced anti-FXa activity by 82% (from 548±87 to 100±41 ng/ml; <i>P</i><0.0001), mean unbound edoxaban plasma concentration by ~80% (from 100±10 to 21±6 ng/ml; <i>P</i><0.0001), and blood loss by 80% vs. vehicle (adjusted for control, 2.6 vs. 12.9 g; <i>P</i> = 0.003). …”

A systematic review and combined analysis of therapeutic drug monitoring studies for oral paliperidone by Georgios Schoretsanitis (4242865)

Feijoa F3 inhibits NF-κB activity in A. MEF cells and B. MEF Atg5^-/- cells. by Noha Ahmed Nasef (760610)

“…<p>Cells were treated with feijoa F3 at 10mg/ml, Torin1 at 1μM/ml, with and without 100ng/ml PAM3CSK4 stimulation. …”

Angiotensin-Induced Abdominal Aortic Aneurysms in Hypercholesterolemic Mice: Role of Serum Cholesterol and Temporal Effects of Exposure by Petra A. Prins (513431)

Additional file 2 of Single-cell profiling reveals periosteal signatures of impaired periosteal cells proliferation in a drill-hole model of type 2 diabetes by Xing Ji (3096735)

“…Effect of FGL2 on Osteoblast Proliferation Under Normal and High Glucose Conditions. A. Osteoblasts were treated with vehicle or varying concentrations of FGL2 (50, 200 ng/mL) under normal (vehicle) and high glucose (4.5 mg/mL) conditions, and relative cell proliferation was assessed after 48 h to compare the effects under these different conditions. …”

AMD3100 is PC-specific, altering PC migration towards SDF1α, but not towards PDGF-BB. by Robert J. Allen Jr. (540312)

“…<b>B</b>) Additionally, AMD3100 treatment of either cell line did not alter adhesion to fibronectin-coated chamber slides. <b>C</b>) After 5×10⁴ diabetic PCs were seeded on a fibronectin-coated 24-transwell insert with a receiver compartment containing media supplemented with either SDF1α (100 mg/ml) or PDGF-BB (100 ng/ml) and allowed to migrate for 20 hours, we found that AMD3100 treatment significantly impaired PC migration towards SDF1α (25% decrease, p<0.05) but not towards PDGF-BB (8.4% decrease, p>0.05). …”

Minimum concentration of Amphotericin B in serum according to the formulation, dose, and daily or prolonged intermittent therapeutic regimen by Leticia Aparecida Schiave (8438409)

“…The geometric mean Cmin tended to decrease with a reduction in the dose and frequency of intermittent L-AmB infusions: 357 ng/mL (100 mg 4 to 5 times/week) > 263 ng/mL (50 mg 4 to 5 times/week) > 227 ng/mL (50 mg 1 to 3 times/week). …”